MedPath

ACD-A

ACD-A (032922700)

Approved
Approval ID

bee8e967-496c-4541-b092-ead6c8c80269

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Nov 1, 2022

Manufacturers
FDA

Fenwal, Inc.

DUNS: 794519020

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Antiocoagulant Citrate Dextrose Solution, Formula A

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code0942-9005
Application NumberBN160918
Product Classification
M
Marketing Category
C73594
G
Generic Name
Antiocoagulant Citrate Dextrose Solution, Formula A
Product Specifications
Route of AdministrationINTRAVENOUS
Effective DateNovember 1, 2022
FDA Product Classification

INGREDIENTS (3)

DEXTROSE MONOHYDRATEActive
Quantity: 2.45 g in 100 mL
Code: LX22YL083G
Classification: ACTIB
ANHYDROUS CITRIC ACIDActive
Quantity: 730 mg in 100 mL
Code: XF417D3PSL
Classification: ACTIB
SODIUM CITRATE, UNSPECIFIED FORMActive
Quantity: 2.2 g in 100 mL
Code: 1Q73Q2JULR
Classification: ACTIB

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.